Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals and Torii Pharmaceutical Expand Collaboration to Combat Common Warts in Global Phase 3 Trial

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced this week an amendment to its existing licensing agreement with Torii Pharmaceutical Co. Ltd. This collaboration marks a critical step …

Verrica Pharmaceuticals and Torii Pharmaceutical Expand Collaboration to Combat Common Warts in Global Phase 3 Trial Read More



Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Earns Key CMS Approval, Streamlining Access to Molluscum Contagiosum Treatment

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has achieved a significant milestone in its commercial strategy. The Centers for Medicare & Medicaid Services (CMS) has issued a permanent …

Verrica Pharmaceuticals Earns Key CMS Approval, Streamlining Access to Molluscum Contagiosum Treatment Read More